Lipid & Metabolic

Resource Center

Slideshows

Research Summaries

Guideline Update

Guideline Update

ACC/AHA Issue 2026 Cholesterol Guideline With Lower LDL Targets, Expanded Risk Assessment

03/18/2026

Anthony Calabro, MA

New guideline recommendations from the ACC/AHA and 9 partner organizations prioritize earlier treatment, refined atherosclerotic cardiovascular disease risk prediction, and broader use of lipid biomarkers...

03/18/2026

Research Summary

woman looking tired in front of her laptop

Research Summary

Hunger Perception Drives Mood Shifts in Healthy Adults More Than Circulating Glucose Levels

03/09/2026

Anthony Calabro, MA

In a 4-week naturalistic cohort study using continuous glucose monitoring and ecological momentary assessment, investigators examined whether day-to-day glucose fluctuations are associated with mood...

03/09/2026

FDA Alert

FDA Alert

FDA Grants Breakthrough Therapy Designation to Plozasiran for Familial Chylomicronemia Syndrome

01/13/2025

Miranda Manier, BA

Plozasiran, a first-in-class RNA interference therapeutic, reduced triglycerides by 80% and lowered the risk of acute pancreatitis by 83% in patients with familial chylomicronemia syndrome, earning FDA...

01/13/2025

research summary

research summary

Association Between Gene Mutations, Enzyme Activity in Acute Intermittent Porphyria

05/20/2024

Leigh Precopio

Researchers examined the epidemiology of hydroxymethylbilane synthase (HMBS) gene defects and activity levels among patients with acute intermittent porphyria to better understand the role of HMBS activity...

05/20/2024

Research Summary

Research Summary

Late-Stage Persistence With Anti-Obesity Medication Varies By Medication, Weight Loss At 6 Months

02/14/2024

Jessica Ganga

Researchers evaluated the early- and later-stage use of various anti-obesity medications in patients.

02/14/2024

May 2026

Current Issue

May 2026